Not So Different: Goodwin Attorneys Discuss Updates to Biosimilars Litigation Guide
March 07, 2021
Key 2020-2021 updates to the Guide to Biosimilars litigation and Regulation in the US encompass antitrust litigation, preliminary injunctions, and a slowdown in litigation.